Atara Biotherapeutics(CH:ATRA)
CH:ATRA
Atara Biotherapeutics earnings date
Atara Biotherapeutics (ATRA) Q2 2022 Earnings Report
0 Followers
CH:ATRA Q2 2022 EPS Results
- Actual EPS
- CHF 3.75
- Consensus EPS
- -CHF 16.56
- Beat/Miss
- Beat by +CHF 20.31
- One Year Ago EPS
- -CHF 18.93
CH:ATRA Q2 2022 Revenue Results
- Actual Revenue
- CHF 42.93M
- Expected Revenue
- CHF 5.69M
- Beat/Miss
- Beat by +CHF 37.24M
- YoY Revenue Growth
- +1232.79%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- After Close
- Conference Call
- Monday, August 8, 2022
CH:ATRA Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ATRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.08- | -0.21 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.11-0.12 | -0.27 | 53.13% (+0.14) | |
| Aug 12, 2026 | 2026 (Q2) | -0.26-0.27 | 0.16 | -268.42% (-0.42) | |
| May 12, 2026 | 2026 (Q1) | -0.27-0.24 | 2.91 | -108.29% (-3.15) | |
| Mar 16, 2026 | 2025 (Q4) | -0.15-0.21 | -0.99 | 78.99% (+0.78) | |
| Nov 29, 2025 | 2025 (Q3) | -0.55-0.27 | -2.44 | 89.08% (+2.17) | |
| Aug 11, 2025 | 2025 (Q2) | -0.050.16 | -2.58 | 106.13% (+2.74) | |
| May 15, 2025 | 2025 (Q1) | -1.652.91 | -4.79 | 160.87% (+7.70) | |
| Mar 07, 2025 | 2024 (Q4) | -2.38-0.99 | -11.65 | 91.50% (+10.66) | |
| Nov 12, 2024 | 2024 (Q3) | -1.57-2.44 | -13.73 | 82.24% (+11.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
